COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,363 Articles (22,803 medRxiv, 8,560 bioRxiv)

Most recent first Previous |  Page 2072: Articles 20711-20720  | Next

Examining the Persistence of Human Coronaviruses on Fresh Produce
Blondin-Brosseau, M., Harlow, J., Doctor, T., Nasheri, N.
10.1101/2020.11.16.385468 — Posted: 2020-11-16 Discussion: Onsite | Offsite
SARS-CoV-2-specific T cell memory is long-lasting in the majority of convalsecent COVID-19 individuals
Li, Z., Liu, J., Deng, H., Yang, X., Wang, H., Feng, X., Zelinskyy, G., Trilling, M., Sutter, K., Lu, M., Wang, B., Yang, D., Zheng, X., Liu, J.
10.1101/2020.11.15.383463 — Posted: 2020-11-16 Discussion: Onsite
Effects of inactivation method on SARS-CoV-2 virion proteins and structure
Loveday, E. K., Hain, K. S., Kochetkova, I., Hedges, J. F., Robison, A., Snyder, D. T., Brumfield, S. K., Young, M. J., Jutila, M. A., Chang, C. B., Taylor, M. P.
10.1101/2020.11.14.383026 — Posted: 2020-11-16
High resolution profiling of pathways of escape for SARS-CoV-2 spike-binding antibodies
Garrett, M. E., Galloway, J., Chu, H. Y., Itell, H. L., Stoddard, C. I., Wolf, C. R., Logue, J. K., McDonald, D., Matsen, F. A., Overbaugh, J.
10.1101/2020.11.16.385278 — Posted: 2020-11-16
Immunological memory to SARS-CoV-2 assessed for greater than six months after infection
Dan, J. M., Mateus, J., Kato, Y., Hastie, K. M., Faliti, C., Ramirez, S. I., Frazier, A., Yu, E. D., Grifoni, A., Rawlings, S. A., Peters, B., Krammer, F., Simon, V., Saphire, E. O., Smith, D., Weiskopf, D., Sette, A., Crotty, S.
10.1101/2020.11.15.383323 — Posted: 2020-11-16 Discussion: Onsite | Offsite
Novel gene-specific translation mechanism of dysregulated, chronic inflammation reveals promising, multifaceted COVID-19 therapeutics
Wang, L., Muneer, A., Xie, L., Zhang, F., Wu, B., Mei, L., Lenarcic, E. M., Feng, E. H., Song, J., Xiong, Y., Yu, X., Wang, C., Gheorghe, C., Torralba, K., Cook, J. G., Wan, Y. Y., Moorman, N. J., Song, H., Jin, J., Chen, X.
10.1101/2020.11.14.382416 — Posted: 2020-11-16
Discovery of rhodomyrtone as a broad-spectrum antiviral inhibitor with anti-SARS-CoV-2 activity
Tang, W., Lu, J., Song, Q.-Y., Li, M.-M., Chen, L.-F., Hu, L.-J., Yang, S.-M., Zhang, D.-M., Wang, Y., Li, Y.-L., Ye, W.-C.
10.1101/2020.11.14.382770 — Posted: 2020-11-16
COVATOR: A Software for Chimeric Coronavirus Identification
Habib, P.
10.1101/2020.11.14.383075 — Posted: 2020-11-16
Evaluation of two RT-PCR techniques for SARS-CoV-2 RNA detection in serum for microbiological diagnosis
Martin Ramirez, A., Zurita Cruz, N. D., Gutierrez-Cobos, A., Rodriguez Serrano, D. A., Gonzalez Alvaro, I., Roy Vallejo, E., Gomez de Frutos, S., Fontan Garcia-Rodrigo, L., Cardenoso Domingo, L.
10.1101/2020.11.15.20231795 — Posted: 2020-11-16
Chest CT features of COVID-19 in the region of Abu Dhabi, UAE- A single institute study
Saeed, G., Al Helali, A., Almazrouei, S., Shah, A., Ahmed, L.
10.1101/2020.11.14.20229096 — Posted: 2020-11-16

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).